Study of sleep medication for delayed sleep phase syndrome
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a sleep medication called lemborexant can help people with delayed sleep phase syndrome fall asleep earlier. It may improve sleep timing and reduce the impact on daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have delayed sleep phase syndrome
- Your sleep is delayed by 2 or more hours compared to your desired bedtime
- You cannot fall asleep earlier if you try
- You are not experiencing severe depression, anxiety, or another sleep disorder
- You are not working night shifts or traveling across time zones during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether timed light flashes can help people whose sleep schedule is consistently delayed (they fall asleep and wake up much later than desired). If you’re still in high school and your main issue is this delayed sleep pattern, you may be able to join.
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This trial tests a sleep medication called lemborexant in people with Parkinson's disease who also have insomnia. The goal is to see if it improves both sleep and movement symptoms.
This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.
This study is testing whether a sleep medication called lemborexant can improve sleep and reduce Alzheimer's-related proteins in healthy older adults with no memory problems. It could help find new ways to delay or prevent Alzheimer's disease.
Hear when a new Delayed Sleep Phase Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.